Groupe Casino - Nombre de droits de vote et d'actions au 31-01-2023 Read more about Groupe Casino - Nombre de droits de vote et d'actions au 31-01-2023
Hermès International: Shares and voting rights as of 31st January 2023 Read more about Hermès International: Shares and voting rights as of 31st January 2023
L'Oréal: News release: "2022 Annual Results" Read more about L'Oréal: News release: "2022 Annual Results"
SAVENCIA FROMAGE & DAIRY: 2022 Annual sales Read more about SAVENCIA FROMAGE & DAIRY: 2022 Annual sales
Excellent 2022 performance in a challenging environment 21% growth to €130.8m, of which 10% organic Confirmed pricing power: strong ability to pass on the increase in agricultural raw materials prices Read more about Excellent 2022 performance in a challenging environment 21% growth to €130.8m, of which 10% organic Confirmed pricing power: strong ability to pass on the increase in agricultural raw materials prices
EDF: Information regarding the voting rights and shares (Article L.233-8-II of the French Commercial Code and 223-16 of the General Regulations of the “AMF”) Read more about EDF: Information regarding the voting rights and shares (Article L.233-8-II of the French Commercial Code and 223-16 of the General Regulations of the “AMF”)
Monthly information related to total number of voting rights and shares composing the share capital _January 31, 2023 Read more about Monthly information related to total number of voting rights and shares composing the share capital _January 31, 2023
Reminder: Cyviz AS - Invitation to presentation of Q4 2022 financial results Read more about Reminder: Cyviz AS - Invitation to presentation of Q4 2022 financial results
Oncodesign Precision Medicine Announces the Initiation of Phase I of its RIPK2 Inhibitor ODS-101, a New Therapeutic Agent for IBD Read more about Oncodesign Precision Medicine Announces the Initiation of Phase I of its RIPK2 Inhibitor ODS-101, a New Therapeutic Agent for IBD